Nosological Tunnel Vision in Biological Psychiatry
A Plea for a Functional Psychopathology
H. M. VAN PRAAG,
G. M. ASNIS,
R. S. KAHN,
S. L. BROWN,
M. KORN,
J. M. HARKAVY FRIEDMAN,
S. WETZLER,
H. M. VAN PRAAG
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorG. M. ASNIS
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorR. S. KAHN
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorS. L. BROWN
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorM. KORN
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorJ. M. HARKAVY FRIEDMAN
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorS. WETZLER
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorH. M. VAN PRAAG,
G. M. ASNIS,
R. S. KAHN,
S. L. BROWN,
M. KORN,
J. M. HARKAVY FRIEDMAN,
S. WETZLER,
H. M. VAN PRAAG
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorG. M. ASNIS
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorR. S. KAHN
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorS. L. BROWN
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorM. KORN
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorJ. M. HARKAVY FRIEDMAN
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorS. WETZLER
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this author
References
- 1 Van Praag, H. M. & B. Leijnse 1965. Neubewertung des syndroms. Skizze einer funktionellen Pathologie. Psychiatr. Neurol. Neurochir. 68: 50–66.
- 2 van Praag, H. M. J. Korf, J. P. W. F. Lakke & T. Schut 1975. Dopamine metabolism in depression, psychoses, and parkinson's diesase: The problem of the specificity of biological variables in behaviour disorders. Psychol. Med. 5: 138–146.
- 3 Van Praag, H. M., R. Kahn, G. M. Asnis, S. Wetzler, S. Brown, A. Bleich & M. Korn 1987a. Denosologization of biological psychiatry on the specificity of 5-HT disturbances in psychiatric disorders. J. Affect. Dis. 13: 1–8.
- 4 van Praag, H. M., G. M. Asnis, S. L. Brown, M. Korn, J. M. Harkavy Friedman & S. Wetzler 1990. Beyond serotonin. A multi-aminergic perspective on abnormal behavior. In Serotonin in Psychiatric Disorders. S. L. Brown and H. M. Praag, Eds. New York : Brunner/Mazel. In press.
- 5 Van Praag, H. M., J. Korf & J. Puite 1970. 5-hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature 225: 1259–1260.
- 6 Brown, S. L., A. Bleich & H. M. Van Praag 1990. The monoamine hypothesis of depression: The case for serotonin. In The Role of Serotonin in the Psychiatric Disorders. S. L. Brown & H. M. Praag, Eds. New York : Brunner/Mazel. In press.
- 7 Van Praag, H. M. 1982. Neurotransmitters and CNS disease: Depression. Lancet II: 1259–1264.
- 8 Goodwin, F. V. & R. M. Post 1983. 5 hydroxytryptamine and depression: A model for the interaction of normal variances and pathology. Br. J. Clin. Pharmacol. 15: 393–3405.
- 9 Van Praag, H. M. & J. Korf 1971. Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification? Psychopharmacology 19: 148–152.
- 10 Van Praag, H. M. & C. Lemus 1986. Monoamine precursors in the treatment of psychiatric disorders. In Nutrition and the Brain. R. J. Wurtman and J. J. Wurtman, Eds. New York : Raven Press, pp. 89–138.
- 11 Van Praag, H. M. 1984. In search of the mode of action of antidepressants: 5-HT-tryosine mixtures in depressions. Neuropharamacology 22: 433–440.
- 12 Van Praag, H. M., C. Lemus & R. Kahn 1987b. Hormonal probes of central serotonergic activity. Do they really exist? Bio. Psych. 22: 86–98.
- 13 Van Praag, H. M. 1986a. Serotonin precursors with and without tyrosine in the treatment of depression.In Biological Psychiatry. C. Shagrass, R. Josias, W. Bridger, K. Weiss & D. Stoff and J. Simpson, Eds. New York : Elsevier Science Publishers Inc.
- 14 Raleigh, M. J. 1987. Differential behavioral effects of tryptophan and 5-hydroxytryptophan in vervet monkeys: Influence of catecholaminergic systems. Psychopharmacology 93: 44–50.
- 15 Asberg, M., L. Traksman & P. Thoren 1976. 5-HIAA in the cerebrospinal fluid: A biochemical suicide predictor? Arch. Gen. Psych. 33: 1193–1197.
- 16 Van Praag, H. M. 1986b. Biological suicide research. Outcome and limitations. Biol. Psych. 21: 1305–1323.
- 17 Brown, G. L., F. K. Goodwin, J. C. Ballenger, P. F. Goyer & L. F. Major 1979. Aggression in humans correlates with cerebrospinal fluid metabolites. Psych. Res. 1: 131–139.
- 18 Brown, G. L., M. E. Ebert, P. F. Goyer, D. C. Jimerson, W. J. Klein, W. E. Bunney & F. K. Goodwin 1982. Aggression, suicide and serotonin: Relationships to CSF amine metabolites. Am. J. Psych. 139: 741–746.
- 19 Bioulac, B., M. Benezich, B. Renaud, B. Noel & D. Roche 1980. Serotonergic functions in the 47, XYZ syndrome. Biol. Psych. 15: 917–23.
- 20 Linnoila, M., M. Virkhunen, M. Scheinin, A. Nuutila, R. Rimon & F. K. Goodwin 1983. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci. 33: 2609–2614.
- 21 Lidberg, L., M. Asberg & U. B. Sundquist-Stensman 1984. 5-Hydroxyindoleacetic acid in attempted suicides who have killed their children. Lancet II: 928.
- 22 Lidberg, L., J. R. Tuck, M. Asberg, G. P. Scalia-Tomba & L. Bertilsson 1985. Homicide, suicide and CSF 5-HIAA. Acta Psychiatr. Scand. 71: 230–236.
- 23 Virkkunen, M., A. Nuutila, F. K. Goodwin & M. Linnoila 1987. Cerebrospinal fluid monoamine metabolite levels in male arsonists. Arch. Gen. Psych. 44: 241–247.
- 24 Plutchik, R., H. M. Van Praag & H. R. Conte 1989. Correlates of suicide and violence risk, III. A 2-stage model of countervailing forces. Psych. Res. 28: 215–225.
- 25 Van Praag, H. M., R. Plutchik & H. Conte 1986. The serotonin-hypothesis of (auto) aggression. Critical appraisal of the evidence. Ann. N.Y. Acad. Sci. 487: 150–167.
- 26 Evans, L. & G. Moore 1981. The treatment of phobic anxiety by zimeldine. Acta Psychiatr. Scand. 63(290): 342–345.
- 27 Koczkas, S., G. Holmberg & L. Wedin 1981. A pilot study of the effect of the 5-HT uptake inhibitor, zimelidine, on phobic anxiety. Acta Psychiatr. Scand. 63(290): 328–341.
- 28 Evans, L., J. Kenardy, P. Schneider & H. Hoey 1986. Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. Acta Psychiatr. Scand. 73: 49–53.
- 29 Kahn, R. S., H. G. M. Westenberg & J. Jolles 1984. Zimelidine treatment of obsessive-compulsive disorder. Acta Psychiatr. Scand. 69: 259–61.
- 30 Kahn, R. S., H. G. M. Westenberg, W. M. A. Verhoeven, C. C. Gispen-de Wied & W. D. J. Kamerbeek 1987. Effect of a serotonin precursor and uptake inhibitor in anxiety disorders: A double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. Inter. Clin. Psychopharmacol. 2: 33–45.
- 31 Den Boer, J. A., H. G. M. Westenberg, W. D. J. Kamerbeek, W. M. A. Verhoeven & R. S. Kahn 1987. Effect of serotonin uptake inhibitors in anxiety disorders: a double-blind comparison of clomipramine and fluvoxamine. Inter. Clin. Psychopharm. 2: 21–32.
- 32 Kahn, R. S. & H. G. M. Westenberg 1985. l-5-Hydroxytryptophan in the treatment of anxiety disorders. J. Affect. Dis. 8: 197–200.
- 33 Kahn, R. S., H. M. van Praag. S. Wetzler, G. M. Asnis & G. Barr 1988. Serotonin and anxiety revisited. Biol. Psych. 23: 189–208.
- 34 Kahn, R. S., S. Wetzler, H. M. Van Praag & G. M. Asnis 1988. Behavioral indications for receptor hypersensitivity in panic disorder. Psych. Res. 25: 101–104.
- 35 Kahn, R. S., S. Wetzler, H. M. Van Praag & G. M. Asnis 1988. Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Psychopharmacology 96: 360–364.
- 36 Taylor, D. P., M. S. Eison, L. A. Riblet & C. P. Vandermaelen 1985. Pharmacological and clinical effects of buspirone. Pharmacol. Biochem. Behav. 23: 687–694.
- 37 Ceulemans, D. L. S., M. I. J. A. Hoppenbrouwers, Y. Gelders & A. J. M. Reyntjens 1985. The influence of ritanserin, a serotonin antagonist, in anxiety disorders: A double-blind placebo-controlled study versus lorazepam. Pharmakopsychiatria 18: 303–305.
- 38 Jones, B. J., B. Costall, A. M. Domeney, M. E. Kelly, R. J. Naylor, N. R. Oakley & M. B. Tyers 1988. The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist. Br. J. Pharmacol. 93: 985–993.
- 39 Banki, C. M. 1977. Correlation between CSF metabolites and psychomotor activity in affective disorders. J. Neurochem. 28: 255–57.
- 40 Rydin, E., D. Schalling & M. Asberg 1982. Rorschach ratings in depressed and suicidal patients with low CSF 5-HIAA. Psych. Res. 7: 229–243.
- 41 Van Praag, H. M. Diagnosing depression. Looking backward into the future. Develop. in Psychiat.
- 42 Apter, A., H. M. van Praag. R. Plutchik, S. Sevy & S. L. Brown 1990. The relationships between a serotonergically linked series of psychopathological dimensions. Psychiatry Res. 32: 191–199.
- 43 Van Praag, H. M., R. Kahn, G. M. Asnis, C. Z. Lemus & S. L. Brown 1987c. Therapeutic indications for serotonin potentiating compounds. A hypothesis. Bio. Psych. 22: 205–212.
- 44 Van Praag, H. M., G. M. Asnis, R. S. Kahn, S. L. Brown, M. Korn, J. M. Harkavy Friedman & S. Wetzler 1990. Monoamines and abnormal behavior. A multiaminergic perspective. Br. J. Psych. In press.
Citing Literature
